Indoco Remedies Board Approves Ophthalmic Division Sale to Sunways for ₹110 Crore
Published on: April 30, 2026, 11:51 p.m. | Source: scanx.trade
Indoco Remedies Board approved the sale of its ophthalmic division to Sunways (India) Private Limited for ₹110 crore through an Agreement to Transfer Business. The division generated ₹47.79 crore revenue (3.2% of standalone revenue) in FY2025. The slump sale transaction covers territories including India and multiple African nations, with expected completion in three months subject to conditions precedent.
